2022 marks the 10th anniversary of a remarkable report that paved the way for the CRISPR gene editing revolution. The senior authors of that study – Jennifer Doudna and Emmanuelle Charpentier – shared the Nobel Prize in Chemistry in 2020 for developing the “genetic scissors” that has already been deployed in the clinic, curing a handful of patients with sickle-cell disease. But for all of its early success and promise, CRISPR has also been at the center of a major controversy. In 2018, gene-edited twin girls were born in China, which triggered an international firestorm.
Why You Should Break Up with
Your Biobank – 2022
Turning to traditional biobanks for samples may seem like an easy choice, but it’s fraught with challenges. Sanguine is leading the #research revolution – changing how researchers access samples with a patient-centric approach focused on harnessing our extensive #patient database to quickly mobilize and recruit even the most challenging patient populations nationwide for on-demand, convenient, at-home sample collection based on your study needs. Here’s why we’re saying you should leave your biobank and team up with us to maximize your study success.
The CRISPR Craze
Kevin Davies, PhD
Author "EDITING HUMANITY: The CRISPR
Revolution and the New Era of Genome Editing"
March 29th, 2022
1:00 pm – 2:00 pm ET
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Weingarten-Gabbay, Klaeger, Sarkizova et al
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans